Bill Maughan
Stock Analyst at Clear Street
(0.87)
# 3,970
Out of 5,106 analysts
20
Total ratings
41.67%
Success rate
-11.72%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Bill Maughan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLLS Cellectis | Initiates: Buy | $9 | $4.88 | +84.43% | 1 | Dec 23, 2025 | |
| WVE Wave Life Sciences | Maintains: Buy | $22 → $47 | $17.48 | +168.88% | 2 | Dec 9, 2025 | |
| ANNX Annexon | Initiates: Buy | $17 | $5.11 | +232.68% | 1 | Dec 2, 2025 | |
| KRRO Korro Bio | Initiates: Buy | $93 | $8.40 | +1,007.14% | 1 | Oct 31, 2025 | |
| DNTH Dianthus Therapeutics | Initiates: Buy | $100 | $42.61 | +134.69% | 1 | Sep 17, 2025 | |
| KRYS Krystal Biotech | Initiates: Buy | $190 | $253.36 | -25.01% | 1 | Jul 1, 2025 | |
| CRSP CRISPR Therapeutics AG | Downgrades: Hold | $45 | $56.46 | -20.30% | 1 | Jun 27, 2025 | |
| NKTX Nkarta | Maintains: Buy | $16 → $15 | $1.80 | +733.33% | 2 | May 10, 2024 | |
| FATE Fate Therapeutics | Maintains: Buy | $11 → $9 | $0.98 | +821.38% | 1 | May 10, 2024 | |
| IMCR Immunocore Holdings | Maintains: Hold | $63 → $67 | $36.19 | +85.13% | 3 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $91 → $106 | $32.29 | +228.28% | 3 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $24 | $0.98 | +2,350.48% | 1 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $6.94 | +764.55% | 1 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $96.90 | -53.56% | 1 | Nov 2, 2023 |
Cellectis
Dec 23, 2025
Initiates: Buy
Price Target: $9
Current: $4.88
Upside: +84.43%
Wave Life Sciences
Dec 9, 2025
Maintains: Buy
Price Target: $22 → $47
Current: $17.48
Upside: +168.88%
Annexon
Dec 2, 2025
Initiates: Buy
Price Target: $17
Current: $5.11
Upside: +232.68%
Korro Bio
Oct 31, 2025
Initiates: Buy
Price Target: $93
Current: $8.40
Upside: +1,007.14%
Dianthus Therapeutics
Sep 17, 2025
Initiates: Buy
Price Target: $100
Current: $42.61
Upside: +134.69%
Krystal Biotech
Jul 1, 2025
Initiates: Buy
Price Target: $190
Current: $253.36
Upside: -25.01%
CRISPR Therapeutics AG
Jun 27, 2025
Downgrades: Hold
Price Target: $45
Current: $56.46
Upside: -20.30%
Nkarta
May 10, 2024
Maintains: Buy
Price Target: $16 → $15
Current: $1.80
Upside: +733.33%
Fate Therapeutics
May 10, 2024
Maintains: Buy
Price Target: $11 → $9
Current: $0.98
Upside: +821.38%
Immunocore Holdings
May 9, 2024
Maintains: Hold
Price Target: $63 → $67
Current: $36.19
Upside: +85.13%
May 3, 2024
Maintains: Hold
Price Target: $91 → $106
Current: $32.29
Upside: +228.28%
Mar 15, 2024
Maintains: Buy
Price Target: $22 → $24
Current: $0.98
Upside: +2,350.48%
Feb 21, 2024
Reiterates: Buy
Price Target: $60
Current: $6.94
Upside: +764.55%
Nov 2, 2023
Initiates: Buy
Price Target: $45
Current: $96.90
Upside: -53.56%